eli lilly's tirzepatide is the leader in weight loss sector Novo Nordisk Says 'Gold Standard' GLP-1 Comparison Misleads Consumers Eli Lilly's $1 Trillion Boom:

In addition to these, drug therapy, such as the use of GLP-1RA in medications for weight loss, has made significant progress

Raza A, Charagh S, Garca-Caparrs P, Rahman MA, Ogwugwa VH, Saeed F, Jin W (2022a) Melatonin-mediated temperature stress tolerance in plants

The classification of Rybelsus as a GLP-1 receptor agonist is reflected in its Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and available on the electronic medicines compendium (emc)

Retatrutide, in clinical trials, is administered via subcutaneous injection, typically once weekly, with doses ranging from 0.5 mg to 12 mg